JP Patent
JP7153083B2 — コロナウイルス感染を治療するための方法および組成物
Assigned to フェニックス・バイオテクノロジー・インコーポレイテッド · Expires 2022-10-13 · 4y expired
What this patent protects
Patent listed against Skyclarys.
Drugs covered by this patent
- Skyclarys (OMAVELOXOLONE) · Biogen Us
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.